First New York Securities’s QIAGEN NV QGENF Stock Holding History

First New York Securities’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-68	Closed	-$1.48K	–	368
2016 Q2	$1.48K	Buy	+68	New	+$1.48K	﹤0.01%	194
2015 Q4	–	Sell	-78,000	Closed	-$2.01M	–	365
2015 Q3	$2.01M	Buy	78,000 +77,990	+779,900%	+$2.01M	0.91%	26
2015 Q2	$248	Buy	+10	New	+$248	﹤0.01%	416
2014 Q2	–	Sell	-41,000	Closed	-$865K	–	506
2014 Q1	$865K	Sell	41,000 -4,540	-10%	-$95.8K	0.42%	59
2013 Q4	$1.08M	Buy	45,540 +27,140	+148%	+$646K	0.66%	34
2013 Q3	$394K	Buy	+18,400	New	+$394K	0.16%	120

Other funds holding QGENF

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return

First New York Securities's QGENF Position: Q3 2016 in Review

First New York Securities sold out of QIAGEN NV (QGENF) in Q3 2016, closing a stake of 68 shares — an estimated $1.48K sold.

First New York Securities first reported a position in QGENF in Q3 2013 and held it in 6 quarters. The position peaked at $2.01M in Q3 2015. 211 funds tracked by Wall St. Rank hold QGENF as of Q3 2016.

First New York Securities reported no remaining QIAGEN NV position as of Q3 2016 after selling out during the quarter.
First New York Securities sold 68 QIAGEN NV shares in Q3 2016, an estimated $1.48K.
First New York Securities first reported a position in QIAGEN NV in Q3 2013 and held it in 6 quarters.
First New York Securities's QIAGEN NV position peaked at $2.01M in Q3 2015.
211 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2016.

Based on First New York Securities's 13F filing for Q3 2016, filed 18 Oct 2016.